Clinical Trial

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

Study acronym: POPF
Recruiting
View on ClinicalTrials.gov →
Summary
Pancreaticoduodenectomy (PD) is a complex procedure performed in patients with malignant or benign tumors of the pancreatic head and periampullary region, associated with high morbidity and mortality. Postoperative pancreatic fistula (POPF) is the most common and clinically significant complication following PD. In this study, the investigators aim to determine the predictive risk factors for clinically related postoperative pancreatic fistula (CR-POPF) in the preoperative, intraoperative and postoperative period in patients that underwent PD. The total number of 100 participants expected to be included in this research who underwent PD between 2025 and 2026.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-06; most recent amendment 2026-06-27.
Status change: Not Yet Recruiting → Recruiting 2025-06-19
Trial Details
NCT Number NCT07022015
Lead Sponsor Minia University
Conditions Pancreas Cancer, Pancreas Neoplasm, Pancreatic Fistula, Pancreas Adenocarcinoma, Periampullary Cancer, Periampullary Carcinoma, Resectable Pancreatic Cancer
Enrollment 100 participants
Start Date 2025-06-20
Primary Completion 2026-09-20 (estimated)
Study Completion 2026-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-01